Leap Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-0.18-0.18-0.21-0.27
Price/Sales ratio
0.7116.480.520.36
Earnings per Share (EPS)
$-1.54$-1.52$-1.29$-1.00

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.66-6.35-2.88-1.92-1.22-0.76-4.85-6.85-0.93-1.03-0.41-1.22
Price/Sales ratio
N/AN/AN/AN/AN/AN/A88.99185.38N/AN/AN/AN/A
Price/Book Value ratio
2.014.98-0.735.143.08-14.462.862.570.861.400.57-14.46
Price/Cash Flow ratio
-5.17-6.84-2.91-2.58-1.08-0.94-5.14-7.90-1.03-1.93-0.46-1.08
Price/Free Cash Flow ratio
-5.11-6.84-2.89-2.57-1.08-0.93-5.14-7.90-1.03-1.93-0.46-1.08
Price/Earnings Growth ratio
0.280.15-0.02-0.100.020.070.07-3.53-0.490.050.300.02
Dividend Yield
N/AN/AN/AN/AN/A1.41%0.22%N/AN/AN/AN/A1.41%
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/A100%100%N/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/A-1902.6%-2761.73%N/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/A-1834.4%-2707.4%N/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/A-1834.26%-2705.8%N/AN/AN/AN/A
Effective Tax Rate
-0.12%-0.72%-16.98%0.52%-0.08%0.00%0.00%0.05%-0.27%N/A-0.17%0.00%
Return on Assets
-52.26%-74.96%-396.96%-102.28%-121.30%-441.72%-50.60%-34.42%-77.60%-111.79%-116.54%-121.30%
Return On Equity
-55.07%-78.53%25.57%-267.40%-252.18%1881.07%-58.97%-37.61%-92.74%-135.37%-105.52%-252.18%
Return on Capital Employed
-45.26%-78.48%92.66%-140.78%-243.61%3222.63%-60.72%-38.38%-96.00%-144.72%-140.40%-243.61%
Liquidity Ratios
Current Ratio
N/AN/A0.114.542.680.497.09N/AN/AN/A6.052.68
Quick Ratio
18.7721.820.114.542.680.497.0911.706.055.645.832.68
Cash ratio
4.3616.390.024.232.520.457.0611.505.835.565.832.52
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/A17.76289.32N/AN/AN/AN/A
Days of Inventory outstanding
N/AN/A438N/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A47.08K19.93K26.65K2.15KN/AN/A4.97K5.52KN/A2.15K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/A0.114.68N/AN/A0.060.000.000.000.000.160.16
Debt Equity Ratio
N/A0.11-0.30N/AN/A-0.270.000.000.000.000.190.19
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
N/A0.10-0.43N/AN/A-0.370.000.000.000.000.010.01
Interest Coverage Ratio
N/AN/A-22.32-267.37-1.57K-1.44K-725.84N/AN/AN/A-902.38-1.57K
Cash Flow to Debt Ratio
N/A-6.23-0.83N/AN/A-56.75-63.62-81.38-117.89-166.99-107.40-56.75
Company Equity Multiplier
1.051.04-0.062.612.07-4.251.161.091.191.211.191.19
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/A-17.30-23.43N/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.001.0011.00111111.00
Cash Flow Coverage Ratio
N/A-6.23-0.83N/AN/A-56.75-63.62-81.38-117.89-166.99-107.40-56.75
Short Term Coverage Ratio
N/A-6.23-0.83N/AN/A-56.75-63.62-81.38-117.89-166.99-175.05-56.75
Dividend Payout Ratio
N/AN/AN/AN/AN/A-1.09%-1.10%N/AN/AN/AN/A-1.09%